undamentalytics Newsletter

Varex Imaging Corp income statement

In fiscal 2025, Varex Imaging Corp reported revenue of $845m, up 4.1% on the year before, operating income of −$27.8m (a -3.3% margin) and net income of −$70.3m, or −$1.70 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Varex Imaging Corp: income statement, annual
Fiscal year2015Oct 20152016Sept 20162017Sept 20172018Sept 20182019Sept 20192020Oct 20202021Oct 20212022Sept 20222023Sept 20232024Sept 20242025Oct 2025LTMJul 2026
Revenue632620698773781738818859893811845865
Cost of revenue382372445520524548547576603554554568
Gross profit251248254254257190272284290257291297
Research and development505467837879727785879191
Selling, general and administrative7386103123128142126118128138133133
Operating income128109844546−3474887732−2872
Interest expense1212222131424029303639
Income before tax128105752622−732945315−5928
Income tax473623−36−151114−1753115
Net income8069522816−58173047−49−7022
Diluted EPS$2.12$1.82$1.36$0.72$0.40−$1.49$0.43$0.73$1.07−$1.20−$1.70$0.56
Diluted shares (average)38m38m38m38m39m39m40m42m50m41m41m40m
EBITDA1371191017169−11951079753−595

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: INSP vs VREXATEC vs VREXOFIX vs VREX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Varex Imaging Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Varex Imaging Corp.